Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Journal of Physics. Condensed Matter : an Institute of Physics Journal|July 10, 2012
Nonmagnetic ground states and phase transitions in the caged compounds PrT2Zn20 (T = Ru, Rh and Ir)T Onimaru, K T Matsumoto, N Nagasawa, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trialA Hata, F Inoue, Y Hamamoto, et al.
British Journal of Haematology|December 24, 1997
Total absence of protein 4.2 and partial deficiency of band 3 in hereditary spherocytosisA Kanzaki, S Hayette, L Morlé, et al.
Endoscopy|April 5, 2002
The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patientsH Nakase, K Okazaki, M Ohana, et al.
Placenta|October 4, 2002
Establishment of feeder-independent cloned caprine trophoblast cell line which expresses placental lactogen and interferon tauH Miyazaki, M Imai, T Hirayama, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 30, 1999
Management of acute metabolic decompensation in maple syrup urine disease: a multi-center studyM Yoshino, K Aoki, H Akeda, et al.
International Journal of Hematology|June 10, 2000
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationK Saito, Y Nakamura, M Aoyagi, et al.
The Japanese Journal of Antibiotics|September 10, 1999
[Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents: special references to bacteria isolated between July 1996 and June 1997]K Mashita, N Shinagawa, S Ishikawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2016
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)K Yamazaki, M Nagase, H Tamagawa, et al.
The Japanese Journal of Antibiotics|January 5, 2002
[Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1998 and March 1999]K Mashita, N Shinagawa, S Ishikawa, et al.
Pageof 18